Axonius has acquired Cynerio for over $100 million to enhance medical device security within healthcare environments.
Information on the Target
Axonius, a leading global provider of cyber asset intelligence, has successfully acquired Cynerio, an innovator specializing in medical device security, for over $100 million in a cash and stock agreement. This acquisition aims to address critical cybersecurity challenges faced by healthcare providers due to the increasing connectivity of medical devices.
With these devices playing an essential role in patient care, they have often remained undetected by traditional security tools, which has led to heightened risks for both patient safety and hospital operations. The integration of Cynerio's expertise will enhance Axonius's capability to secure these vital assets.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target's Specific Country
The healthcare cybersecurity landscape has been evolving rapidly, particularly in the United States, where the need for robust security solutions is paramount. As healthcare providers increasingly integrate connected medi
Similar Deals
Bambu Ventures → Lemonaid Health
2026
Heartland Dental → Smile Design Dentistry
2025
Sun Pharmaceutical Industries Limited → Checkpoint Therapeutics, Inc.
2025
Court Square Capital and WindRose Health Investors → Soleo Health
2025
Supernus Pharmaceuticals, Inc. → Sage Therapeutics, Inc.
2025
SERB Pharmaceuticals → Y-mAbs Therapeutics
2025
Axonius
invested in
Cynerio
in 2025
in a Buyout deal
Disclosed details
Transaction Size: $100M